🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The PERCHE trial evaluated the worth of adding adjuvant chemotherapy for pr...
Status
Terminated
Location
National Institute of Oncology
Start Date
2003-08
Trial ID
NCT00066807
Treatments Being Tested
The investigators designed this study to investigate the effect of aromatas...
Status
Unknown
Location
Zhejiang Cancer Hospital
Start Date
2016-05
Trial ID
NCT02769104
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy, such as docetaxel, doxorubicin , cyc...
Status
Completed
Location
Lurleen Wallace Comprehensive Cancer at University of Alabama - Birmingham
Start Date
2004-10
Trial ID
NCT00093795
Treatments Being Tested
This phase I trial studies the side effects and how well pevonedistat, azac...
Status
Completed
Location
Children's Hospital of Alabama
Start Date
2019-05-17
Trial ID
NCT03813147
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of Camreli...
Status
Unknown
Location
Aiping Shi
Start Date
2021-09-20
Trial ID
NCT05088057
Treatments Being Tested
The purpose of this study is to assess the safety and efficacy of pembroliz...
Status
Active Not Recruiting
Location
Multiple Locations
Start Date
2016-11-17
Trial ID
NCT02861573
RATIONALE: Drugs used in chemotherapy work in different ways to stop the gr...
Status
Completed
Location
Providence Alaska Medical Center
Start Date
2012-04
Trial ID
NCT01547741
Treatments Being Tested
Treatment consists of 4 AC cycles followed by 2 weekly docetaxel cycles (12...
Status
Completed
Location
Hospital Universitario Germans Trias i Pujol
Start Date
2003-02
Trial ID
NCT00129376
Treatments Being Tested
This phase II clinical trial is studying how well giving busulfan, fludarab...
Status
Completed
Location
Beebe Medical Center
Start Date
2010-07-15
Trial ID
NCT01168219
This study is an open label, multicenter study. Subjects are randomized at ...
Status
Enrolling By Invitation
Location
Tianjin Medical University Cancer Insititute & Hospital
Start Date
2023-01-01
Trial ID
NCT05678933
Treatments Being Tested